The presence of higher levels of PD-1 and PD-L1 on monocytes from severe COVID-19 has been linked to metabolic dysfunctions, even if altered mitochondrial ultrastructure are unable to impair their ability to produce pro-inflammatory cytokines13. This evidence concerns the gene CD274 and COVID-19.